Lapix Therapeutics Inc. is a clinical-stage biopharmaceutical company based in Cambridge, MA, dedicated to developing innovative oral therapeutics that restore immune system function for patients with autoimmune diseases. Through a patient-centric approach, Lapix Therapeutics is pioneering treatments that enhance the body's natural immune tolerance.
Company Values
Lapix stands out by focusing on immune system restoration without broadly suppressing immunity, providing a gentler alternative to existing autoimmune therapies.